Perrigo (PRGO) to Acquire Rosemont Pharma in $283M Deal; Sees FY13 EPS to Strong-Side of Consensus

February 11, 2013 8:46 AM EST Send to a Friend
Perrigo Co (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login